M3, Inc. (MTHRF) Stock Price & Analysis
M3, Inc. (MTHRF) — price $10.36 (0.00%), as of the Nov 19, 2026 trading session; market cap $6.89B.
Educational signal · not a buy or sell recommendation · How to read this
M3, Inc. · MTHRF
is a leading Japanese healthcare information services provider, focusing on internet-based solutions for medical professionals.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $10.36 | |
| Change on the day | 0.00% | |
| Market capitalisation | $6.89B | — |
| Price / earnings (trailing) | 25.29 | |
| Shares traded on the day | 5.2K |
Price & events
Other perspectives
Council score for M3 (MTHRF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 20, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is M3 (MTHRF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. M3, Inc. (MTHRF) is the company analyzed here. It employs 17,010 people. The market values it at $6.89B.
What are the financial strengths and risks for M3 (MTHRF)?
Short answer
The distress and quality screens read Altman Z 4.98 · Piotroski F 5. Trailing ratios: ROE 11.8% · ROA 6.9% · current ratio 2.44.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MTHRF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MTHRF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
M3 Stock: Key Questions Answered
These answers are editorial: they are written from question templates that restate figures shown above. They are not part of the source register.
Is MTHRF a good stock to buy?
Stock Expert AI does not rate MTHRF buy, sell or hold. M3, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the MTHRF stock price today?
The last price recorded for M3, Inc. (MTHRF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the key factors to evaluate for MTHRF?
Evaluate MTHRF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Not financial advice.
How frequently does MTHRF data refresh on this page?
MTHRF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven MTHRF's recent stock price performance?
(MTHRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio of digital platforms tailored for healthcare professionals. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MTHRF overvalued or undervalued right now?
(MTHRF) trades at 25.29x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MTHRF before investing?
Before investing in M3, Inc. (MTHRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MTHRF to a portfolio?
Key strength of M3, Inc. (MTHRF): Diverse portfolio of digital platforms tailored for healthcare professionals. Weigh rewards against risks and diversify. Not financial advice.
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 9 figures on this page — 6 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com